Analysts/Institutional Investor Meet/Con. Call Updates

30th October, 2026 BSE Limited National Stock Exchange of India Limited P.J. Towers, Dalal Street, Fort, Exchange Plaza, Bandra-Kurla Complex, Bandra Mumbai- 400 001 (East), Mumbai – 400 051 BSE scrip code: 543635 NSE symbol: PPLPHARMA Sub: Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir / Madam, We wish to inform you that pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the schedule of Institutional Investor Meetings with the Company is as under: Date Name of Analyst/Investor Nature of Meeting Mode Venue Meet 17th Institutional Investor Meeting Group / One-on-one Physical Mumbai November, arranged by Avendus Spark Meeting 2026 18th Institutional Investor Meeting Group / One-on-one Physical Mumbai November, arranged by JM Financial Meeting 2026 Service Note: Dates are subject to changes. Changes may happen due to exigencies on the part of Investors / Company. Kindly take the above on record. Thank you. Yours truly, For Piramal Pharma Limited Maneesh Sharma Company Secretary & Compliance Officer Piramal Pharma Limited CIN: L24297MH2020PLC338592 Registered Office: Ananta Building, Piramal Corporate Park, Opp. Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai – 400070, Maharashtra, India Tel No. +91 22 3802 3000 / 4000; Email Id: shareholders.ppl@piramal.com www.piramalpharma.com